semaglutide us Oral Lowers HbA1c in Phase 3 Trial in Youth With Type 2 Diabetes Type 2 diabetes: New Ozempic
Description
FDA has approved Wegovy, the weekly semaglutide treatment for obesity fromNovo Nordisk
Up to 40% of weight lost on semaglutide may be lean mass
Rocket-like launches created unprecedented demand, stressed supply chains, and caused payers world-wide to question their ability to pay for obesity treatment
Semglee is the first interchangeable biosimilar product approved in the U.S
This launch coincides with the patent expiry of the innovator's drug
